builderall

CONFERENCE INFORMATION

Conference Description

This conference is the premier destination for oncology pharmacy professionals and interdisciplinary oncology team members to engage in the exchange of current and emerging cancer pharmacotherapies, precision medicine advances, and innovative practice management strategies. As the oncology treatment landscape evolves rapidly, this activity will promote collaboration among oncology pharmacists, clinicians, and practice leaders to enhance the delivery of evidence-based, patient-centered care.

Designed to support informed decision-making and improve patient outcomes, the program will provide a comprehensive review of the latest developments in oncology therapeutics, molecular diagnostics, therapy monitoring, and supportive care. Sessions will also address strategies for navigating financial and operational challenges in practice, optimizing value-based care, and integrating cutting-edge technologies into pharmacy workflows. This educational opportunity will empower pharmacists and the broader care team to contribute meaningfully to cancer care optimization and patient safety.

Join us as we unite the oncology pharmacy community of South Florida, along with other industry stakeholders, in our journey to continue to drive transformative possibilities in cancer care. It is in our collective efforts that lies the opportunity to elevate cancer care delivery and patient outcomes.

Target Audience & Expected Audience

This activity is designed for oncology pharmacists, pharmacy residents and students with an interest in oncology, and pharmacy technicians. The conference also welcomes the broader multidisciplinary oncology care team, including physicians, advanced practice providers (NPs and PAs), nurses, and practice administrators who collaborate in delivering high-quality cancer care.

Expected attendance: 75–100 oncology pharmacists and oncology-focused professionals.

Learner Objectives

Upon completion of this conference, participants will be able to:

  • At the conclusion of this activity, participants should be better able to:

  • Describe emerging oncology pharmacotherapy options and their mechanisms of action to support evidence-based treatment selection.

  • Evaluate patient- and drug-specific considerations for managing, monitoring, and adjusting oncology therapies to mitigate adverse effects and enhance therapeutic benefit.

  • Apply principles of precision medicine and molecular diagnostics to guide individualized cancer pharmacotherapy decision-making.

  • Develop strategies to improve adherence, optimize outcomes, and support transitions of care in oncology pharmacy practice.

  • Identify practice management innovations and operational efficiencies that enhance the value and sustainability of cancer care delivery.